A non-hallucinogenic psychedelic analogue with therapeutic potential

Lindsay P. Cameron(University of California, Davis), David E. Olson(Multidisciplinary Association for Psychedelic Studies), Dorit Ron(University of California, San Francisco), Bianca Yaghoobi(University of California, Davis), Pamela J. Lein(University of California, Davis), Heike Wulff(University of California, Davis), Matthew N. McCarroll(University of California, San Francisco), Alexander J. Pell(University of California, Davis), Michelle Tjia(University of California, Santa Cruz), Yi Zuo(University of California, Santa Cruz), Maxemiliano V. Vargas(University of California, Davis), John D. McCorvy(Medical College of Wisconsin), Lee E. Dunlap(University of California, Davis), Zefan Q. Hurley(University of California, Davis), Jack C. Taylor(University of California, San Francisco), Taohui Liu(University of California, Santa Cruz), Robert J. Tombari(University of California, Davis), David Kokel(University of California, San Francisco), Ju Lu(Harvard University), Yann Ehinger(University of California, San Francisco), Zachary Rabow(University of California, Davis), Oliver Fiehn(King Abdulaziz University), Jamie Peters(University of Colorado Anschutz Medical Campus), Jayashri Viswanathan(University of California, Davis), Guoliang Zhang(University of California, Davis), Brandon M. Brown(University of California, Davis), Douglas Myers-Turnbull(QB3), Emilie I. Anderson(Medical College of Wisconsin), Lauren J. Laskowski(Medical College of Wisconsin)
Nature
December 9, 2020
Cited by 461


Related Papers